by David Rosado | Oct 31, 2022 | Blog
Source: Parexel News Release BOSTON and Durham, N.C. May 20, 2021 — Parexel, a leading global clinical research organization (CRO), today announced the release of “Discussions on Diversity,” an in-depth research report and interactive microsite featuring patient,...
by ChristinaSilva | Mar 21, 2022 | Blog
In 2015, the U.S. Food and Drug Administration launched a five-year action plan, aiming to improve diversity in clinical trials for newly approved drugs. According to HealthDay, Angela K. Green, M.D., from the Memorial Sloan Kettering Cancer Center in New York City,...
by Nicholas Baudoin | Mar 21, 2022 | 2022
In 2015, the U.S. Food and Drug Administration launched a five-year action plan, aiming to improve diversity in clinical trials for newly approved drugs. According to HealthDay, Angela K. Green, M.D., from the Memorial Sloan Kettering Cancer Center in New York...
by ChristinaSilva | Aug 7, 2020 | Blog
COVID-19 vaccine trials have moved into phase three. Two trials were launched in the United States and researchers are looking to enroll 30,000 people for each trial. They are working to ensure that a significant percentage of volunteers come from the places hit...